Product logins

Find logins to all Clarivate products below.


Heart Valve Devices | Europe | 2015 | Market Analysis

Adoption of THV devices will continue to fuel market growth through 2023; in particular, improvements to TAVR devices and emerging TMVR devices will result in increased penetration into surgical procedures.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for heart valve devices in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Biosurgical Agents – Market Insights – Europe
The Europe biosurgical agent market will exhibit modest growth over the forecast period. This expansion will be fueled by a continued preference for biosurgical agents over alternative solutions,…
Report
Trauma Devices – Market Insights – Europe
Although financial constraints among European healthcare facilities and the rise of GPOs that will exert downward pressure on ASPs will limit the European trauma device market, favorable…
Report
Heart Valve Devices – Market Insights – United States
The US heart valve device market continues to be driven by the introduction of novel products and key approvals for new indications of existing products. In particular, recent approvals of…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…